Skip to main content

Immune Response BioPharma, Inc.

Home
Drug Discovery
Press Releases
Investor Relations
Royalties
Stock Information
Executive Team
Scientific Board
Clinical Trials
REMUNE Vaccine
REMUNE Rx Co-pay Card
REMUNE FULL PRESCRIBING
REMUNEX Vaccine
Remune Pediatric
RemuneVax Vaccine
NeuroVax Vaccine
NeurOral
RAVAX Vaccine
RAVAX II Vaccine
Zorcell Vaccine
DermaVax
Immunereszumab
Sepsicillin
Rare Diseases
Alliances
Vaccines Direct
Partnering
Bio Defense
Immune Response Hospital
Orchestra Therapeutics
Research Donations
About Us
Corporate Filings
Corporate ByLaws
Transfer Agent
Employment
Events
Webcast
Contact Us
Email Alerts
Member Login
Site Map
Immune Response BioPharma, Inc. TM         Copyright © 2010-2018

Executive Team:
undefined
Immune Response BioPharma, Inc. Executive Team:

Chief Executive Officer : Mr. David Buswell

Mr. David Buswell is founder of Immune Response BioPharma, and is Chief Executive Officer, and is Chairman of the Board of Directors. 

Mr. Buswell holds a Bachelor’s degree in Business & Commerce from the University of Mary Washington, and a Master’s degree MA in Management & Leadership from Liberty University.

2005 UMW.edu Graduate List  UMW2005     2011  Liberty.edu Graduate List

 

President of Corporate Communications & Investor Relations: Mr. Eric Swanson 

Mr. Eric Swanson is President of Corporate Communications and Investor Relations and a member of the Board of Directors. Mr. Swanson holds a Bachelor’s degree from the USC, University of Southern California and has held director positions at King World Productions and was Vice President of Madison Square Garden’s Sports Television Networks.

 

Chief Research & Development Officer & President: Dr. Richard Bartholomew

& a member of the Board of Directors
 

Dr. Richard Bartholomew has over 25 years of R&D experience in the biotech field

Holds Degrees from University of Utah and is co-inventor of NeuroVax 

  • VP of R/D at The Immune Response Corporation
  • Sr. Director, R/D and applied Technology at Hybritech, Inc
  • Education
  • Scripps Clinic and Research Foundation
  • University of Utah
  • University of Utah School of Medicine

 

Chief Science Officer & Scientific Director: Dr. Arthur Vandenbark
and a member of the Board of Directors
 
Dr. Arthur Vandenbark has a Ph.D. from Washington State University 1973, is a Neurologist with vast experience in Neurology 

and is the primary inventor of NeuroVax, currently a Professor at OHSU.edu in the Molecular Microbiology & Immunology Neuroscience Graduate Program and Neurology.
 

Board of Directors Member:  Dr. Halina Offner
 
Dr. Offner  is a Professor & Researcher in the Neurology Department at OHSU, her research includes Multiple Sclerosis, the use of estrogen in 
neurology, autoimmunity, neuroimmunology, stroke, and auto-immune diseases. 

Dr. Offner's work has been published or peer reviewed in over 250 articles & book chapters in press.
 
  
 
undefined
Immune Response BioPharma, Inc. TM
Copyright © 2010-2018   www.immuneresponse.net  All Rights Reserved